UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 21, 2023

Accession Number:	0001193125-23-045595
Submission Type:	POS AM
CIK: 0001001233 Company Name: SANGAMO THERAPEUTICS, INC File Number: 333-255792